Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity | Wiener Medizinische Wochenschrift
Cancers | Free Full-Text | A Cohort Study of Free Light Chain Ratio in Combination with Serum Protein Electrophoresis as a First-Line Test in General Practice
Blood stem cell transplantation to treat cystic lung light chain deposition disease | European Respiratory Society
The pathogenesis of renal injury and treatment in light chain deposition disease | Journal of Translational Medicine | Full Text
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Multiple Myeloma ICD 10 Code | Power
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real‐world investigation - Rosenstein - 2021 - Journal of Neurochemistry - Wiley Online Library
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
Pathology Outlines - Light chain cast nephropathy
Diagnosis and Management of the Cardiac Amyloidoses | Circulation